Rahul Bhargava: Multiple Myeloma – the Poster Child of Innovation
Rahul Bhargava, Director and Head of Hematology, Hematoncology and Stem Cell Transplant at Fortis Health Care, posted on LinkedIn:
”Modern medicine – hope for all
Multiple Myeloma – the Poster Child of Innovation”
Multiple Myeloma truly stands as the poster boy of innovation and progress in modern hematology.
Every passing year brings a new wave of hope -breakthrough drugs, smarter combinations, and longer survival for patients once considered refractory.
We recently witnessed the remarkable impact of one such therapy in a 6th-line refractory patient post Car T cell -a reminder that science, perseverance, and timely access can turn despair into possibility.
We are living in extraordinary times where innovation is rewriting survival curves.
All we need is the means and momentum to ensure every patient benefits.
That’s why we can’t afford relapse -not in science, not in spirit.
God bless the progress, the patients, and the people behind this revolution.
Great work Heme Team
Center of excellence for myeloma and lymphoma FMRI gurugram
Anusha S., Nikhil M Kumar, Yashpal Singh Rawat, Rachit Agrawal, Devyani Surange, Aastha Gupta, Dr. Neha Rastogi Panda.”
Stay updated with Hemostasis Today.
-
Dec 1, 2025, 15:35Frailty’s Impact on Outcomes After Acute Myocardial Infarction
-
Dec 1, 2025, 15:33Elias Bouchi: Celebrating Hemostasis in EEMEA!
-
Dec 1, 2025, 15:32Empowering the Bleeding Disorders Community Through Data․ WFH Workshop Recap
-
Dec 1, 2025, 15:32Alexandru Stieber on a Curious Finding: GLP-1 RAs and the Risk of Optic Neuropathy
-
Dec 1, 2025, 15:31Register for the Women with Bleeding Disorders Summit 2026! – EHC
-
Dec 1, 2025, 15:30Jim Hoffman on a Critical Question: Should We Track NETosis and Use Blood Purification in Heart Failure?
-
Dec 1, 2025, 15:27It’s Time for November’s Learning Update! – ISBT
-
Dec 1, 2025, 15:26Marilena Vrana: “Meet Me in Milan” Should Be the Global Plasma Community’s Pass-Along Catchphrase
-
Dec 1, 2025, 15:25Maartje van den Biggelaar: LSBR Awarded Our Consortium the LSBR Anniversary Grant of €1.6 Million to Launch HemoTwin-BD